Diffuse large B-cell lymphoma trials in Sweden
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleCAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
- Where
- Huddinge, Uppsala
- Age
- 18 years and over
- People
- 18
- Run by
- Uppsala University
See details and how to joinNCT06002659 · EU 2024-511844-18-00 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Gothenburg
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 2Not yet taking people in SwedenHOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before
- Where
- DO NOT EDIT
- Age
- 65 years and over
- People
- 276 worldwide
- Run by
- Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
See details and how to join2025-524230-25-00 · EU 2025-524230-25-00 - Phase 1/2Taking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Gothenburg, Stockholm
- Age
- 18 years and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - Phase 2Taking peopleEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Uppsala
- Age
- 18 years to 70 years
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00 - Phase 2Taking peopleVaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
- Where
- Gothenburg, Linköping, Lund, Stockholm, Uppsala
- Age
- 18 years to 45 years
- People
- 100
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06793410 - Phase 3Taking peopleA Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
- Where
- Boras, Gothenburg, Halmstad, Kalmar, Linkoping, Lulea, Lund, Orebro, Solna, Trollhattan, Umeå, Uppsala, Varberg
- Age
- 75 years and over
- People
- 300 worldwide
- Run by
- Nordic Lymphoma Group
See details and how to joinNCT04332822 · EU 2022-502887-19-00